Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Universität Duisburg-Essen
Stanford University
Stanford University
Massachusetts General Hospital
Chinese PLA General Hospital
Fudan University
Third Affiliated Hospital, Sun Yat-Sen University
Chang Gung Memorial Hospital
Huazhong University of Science and Technology
Huazhong University of Science and Technology